Stereotactic radiotherapy of pancreatic cancer: a systematic review on pain relief

Milly Buwenge,1 Gabriella Macchia,2 Alessandra Arcelli,1 Rezarta Frakulli,3 Lorenzo Fuccio,4 Sara Guerri,1 Elisa Grassi,1 Silvia Cammelli,1 Francesco Cellini,5 Alessio G Morganti1 1Department of Experimental, Diagnostic and Specialty Medicine – DIMES, University of Bologna, S. Orsola-Malpi...

Full description

Bibliographic Details
Main Authors: Buwenge M, Macchia G, Arcelli A, Frakulli R, Fuccio L, Guerri S, Grassi E, Cammelli S, Cellini F, Morganti AG
Format: Article
Language:English
Published: Dove Medical Press 2018-10-01
Series:Journal of Pain Research
Subjects:
Online Access:https://www.dovepress.com/stereotactic-radiotherapy-of-pancreatic-cancer-a-systematic-review-on--peer-reviewed-article-JPR
_version_ 1818981997037486080
author Buwenge M
Macchia G
Arcelli A
Frakulli R
Fuccio L
Guerri S
Grassi E
Cammelli S
Cellini F
Morganti AG
author_facet Buwenge M
Macchia G
Arcelli A
Frakulli R
Fuccio L
Guerri S
Grassi E
Cammelli S
Cellini F
Morganti AG
author_sort Buwenge M
collection DOAJ
description Milly Buwenge,1 Gabriella Macchia,2 Alessandra Arcelli,1 Rezarta Frakulli,3 Lorenzo Fuccio,4 Sara Guerri,1 Elisa Grassi,1 Silvia Cammelli,1 Francesco Cellini,5 Alessio G Morganti1 1Department of Experimental, Diagnostic and Specialty Medicine – DIMES, University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy; 2Radiation Oncology Unit, Research and Care Foundation “Giovanni Paolo II”, Catholic University of Sacred Heart, Campobasso, Italy; 3Radiation Oncology Unit, Bellaria Hospital, Bologna, Italy; 4Department of Medical and Surgical Sciences – DIMEC, University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy; 5Department of Radiotherapy, “A. Gemelli” Hospital, Catholic University, Rome, Italy Abstract: Locally advanced pancreatic carcinoma (LAPC) has a poor prognosis and the purpose of treatment is survival prolongation and symptom palliation. Radiotherapy has been reported to reduce pain in LAPC. Stereotactic RT (SBRT) is considered as an emerging radiotherapy technique able to achieve high local control rates with acceptable toxicity. However, its role in pain palliation is not clear. To review the impact on pain relief with SBRT in LAPC patients, a literature search was performed on PubMed, Scopus, and Embase (January 2000–December 2017) for prospective and retrospective articles published in English. Fourteen studies (479 patients) reporting the effect of SBRT on pain relief were finally included in this analysis. SBRT was delivered with both standard and/or robotic linear accelerators. The median prescribed SBRT doses ranged from 16.5 to 45 Gy (median: 27.8 Gy), and the number of fractions ranged from 1 to 6 (median: 3.5). Twelve of the 14 studies reported the percentage of pain relief (in patients with pain at presentation) with a global overall response rate (complete and partial response) of 84.9% (95% CI, 75.8%–91.5%), with high heterogeneity (Q2 test: P<0.001; I2=83.63%). All studies reported toxicity data. Acute and late toxicity (grade ≥3) rates were 3.3%–18.0% and 6.0%–8.2%, respectively. Reported gastrointestinal side effects were duodenal obstruction/ulcer, small bowel obstruction, duodenal bleeding, hemorrhage, and gastric perforation. SBRT achieves pain relief in most patients with pancreatic cancer with an acceptable gastrointestinal toxicity rate. Further prospective studies are needed to define optimal dose/fractionation and the best systemic therapies modality integration to reduce toxicity and improve the palliative outcome. Finally, the quality of life and, particularly, pain control should be considered as an endpoint in all future trials on this emerging treatment technique. Keywords: radiotherapy, pancreatic neoplasms, systematic review, palliative, pain
first_indexed 2024-12-20T17:40:12Z
format Article
id doaj.art-00faa27ac4e44234a8ec5b33ad4791e5
institution Directory Open Access Journal
issn 1178-7090
language English
last_indexed 2024-12-20T17:40:12Z
publishDate 2018-10-01
publisher Dove Medical Press
record_format Article
series Journal of Pain Research
spelling doaj.art-00faa27ac4e44234a8ec5b33ad4791e52022-12-21T19:31:07ZengDove Medical PressJournal of Pain Research1178-70902018-10-01Volume 112169217841130Stereotactic radiotherapy of pancreatic cancer: a systematic review on pain reliefBuwenge MMacchia GArcelli AFrakulli RFuccio LGuerri SGrassi ECammelli SCellini FMorganti AGMilly Buwenge,1 Gabriella Macchia,2 Alessandra Arcelli,1 Rezarta Frakulli,3 Lorenzo Fuccio,4 Sara Guerri,1 Elisa Grassi,1 Silvia Cammelli,1 Francesco Cellini,5 Alessio G Morganti1 1Department of Experimental, Diagnostic and Specialty Medicine – DIMES, University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy; 2Radiation Oncology Unit, Research and Care Foundation “Giovanni Paolo II”, Catholic University of Sacred Heart, Campobasso, Italy; 3Radiation Oncology Unit, Bellaria Hospital, Bologna, Italy; 4Department of Medical and Surgical Sciences – DIMEC, University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy; 5Department of Radiotherapy, “A. Gemelli” Hospital, Catholic University, Rome, Italy Abstract: Locally advanced pancreatic carcinoma (LAPC) has a poor prognosis and the purpose of treatment is survival prolongation and symptom palliation. Radiotherapy has been reported to reduce pain in LAPC. Stereotactic RT (SBRT) is considered as an emerging radiotherapy technique able to achieve high local control rates with acceptable toxicity. However, its role in pain palliation is not clear. To review the impact on pain relief with SBRT in LAPC patients, a literature search was performed on PubMed, Scopus, and Embase (January 2000–December 2017) for prospective and retrospective articles published in English. Fourteen studies (479 patients) reporting the effect of SBRT on pain relief were finally included in this analysis. SBRT was delivered with both standard and/or robotic linear accelerators. The median prescribed SBRT doses ranged from 16.5 to 45 Gy (median: 27.8 Gy), and the number of fractions ranged from 1 to 6 (median: 3.5). Twelve of the 14 studies reported the percentage of pain relief (in patients with pain at presentation) with a global overall response rate (complete and partial response) of 84.9% (95% CI, 75.8%–91.5%), with high heterogeneity (Q2 test: P<0.001; I2=83.63%). All studies reported toxicity data. Acute and late toxicity (grade ≥3) rates were 3.3%–18.0% and 6.0%–8.2%, respectively. Reported gastrointestinal side effects were duodenal obstruction/ulcer, small bowel obstruction, duodenal bleeding, hemorrhage, and gastric perforation. SBRT achieves pain relief in most patients with pancreatic cancer with an acceptable gastrointestinal toxicity rate. Further prospective studies are needed to define optimal dose/fractionation and the best systemic therapies modality integration to reduce toxicity and improve the palliative outcome. Finally, the quality of life and, particularly, pain control should be considered as an endpoint in all future trials on this emerging treatment technique. Keywords: radiotherapy, pancreatic neoplasms, systematic review, palliative, painhttps://www.dovepress.com/stereotactic-radiotherapy-of-pancreatic-cancer-a-systematic-review-on--peer-reviewed-article-JPRRadiotherapyPancreatic neoplasmsSystematic reviewPalliativePain.
spellingShingle Buwenge M
Macchia G
Arcelli A
Frakulli R
Fuccio L
Guerri S
Grassi E
Cammelli S
Cellini F
Morganti AG
Stereotactic radiotherapy of pancreatic cancer: a systematic review on pain relief
Journal of Pain Research
Radiotherapy
Pancreatic neoplasms
Systematic review
Palliative
Pain.
title Stereotactic radiotherapy of pancreatic cancer: a systematic review on pain relief
title_full Stereotactic radiotherapy of pancreatic cancer: a systematic review on pain relief
title_fullStr Stereotactic radiotherapy of pancreatic cancer: a systematic review on pain relief
title_full_unstemmed Stereotactic radiotherapy of pancreatic cancer: a systematic review on pain relief
title_short Stereotactic radiotherapy of pancreatic cancer: a systematic review on pain relief
title_sort stereotactic radiotherapy of pancreatic cancer a systematic review on pain relief
topic Radiotherapy
Pancreatic neoplasms
Systematic review
Palliative
Pain.
url https://www.dovepress.com/stereotactic-radiotherapy-of-pancreatic-cancer-a-systematic-review-on--peer-reviewed-article-JPR
work_keys_str_mv AT buwengem stereotacticradiotherapyofpancreaticcancerasystematicreviewonpainrelief
AT macchiag stereotacticradiotherapyofpancreaticcancerasystematicreviewonpainrelief
AT arcellia stereotacticradiotherapyofpancreaticcancerasystematicreviewonpainrelief
AT frakullir stereotacticradiotherapyofpancreaticcancerasystematicreviewonpainrelief
AT fucciol stereotacticradiotherapyofpancreaticcancerasystematicreviewonpainrelief
AT guerris stereotacticradiotherapyofpancreaticcancerasystematicreviewonpainrelief
AT grassie stereotacticradiotherapyofpancreaticcancerasystematicreviewonpainrelief
AT cammellis stereotacticradiotherapyofpancreaticcancerasystematicreviewonpainrelief
AT cellinif stereotacticradiotherapyofpancreaticcancerasystematicreviewonpainrelief
AT morgantiag stereotacticradiotherapyofpancreaticcancerasystematicreviewonpainrelief